ArticleScientific reports2024

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation.

Chawalit Ngernsombat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.